In addition to well-known BRAF, RAS, and RET mutations, NGS technology facilitated detection of new somatic alterations in thyroid cancer such as MITF, MDM2, JAK3, FLI1, IDH1 etc. [20], all in which the significance of thyroid cancer has not been delineated yet. This evidence concerns the gene BRAF and thyroid cancer.